Search Results - "MALKIN, M. G"

Handheld cellular telephones and risk of acoustic neuroma by MUSCAT, J. E, MALKIN, M. G, SHORE, R. E, THOMPSON, S, NEUGUT, A. I, STELLMAN, S. D, BRUCE, J

“…The hypothesis that intracranial energy deposition from handheld cellular telephones causes acoustic neuroma was tested in an epidemiologic study of 90…”
Get full text

Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases : a phase I trial by OMURO, A. M, RAIZER, J. J, DEMOPOULOS, A, MALKIN, M. G, ABREY, L. E

“…Temozolomide (TMZ) has shown modest efficacy in the treatment of recurrent brain metastasis (BM). We designed a new regimen utilizing dose-intensified,…”
Get full text

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma by Schmainda, Kathleen M., Prah, Melissa, Connelly, Jennifer, Rand, Scott D., Hoffman, Raymond G., Mueller, Wade, Malkin, Mark G.

“…Background The anti-VEGF antibody, bevacizumab, is standard treatment for patients with recurrent glioblastoma. In this setting, traditional anatomic MRI…”
Get full text

PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma by PERRY, J. R., JULIAN, J. A., LAPERRIERE, N. J., GEERTS, W., AGNELLI, G., ROGERS, L. R., MALKIN, M. G., SAWAYA, R., BAKER, R., FALANGA, A., PARPIA, S., FINCH, T., LEVINE, M. N.

“…Background and objectives: Venous thromboembolism (VTE) occurs in 20–30% of patients with malignant glioma per year of survival. We tested the efficacy of…”
Get full text

Safe and Cost Effective Use of Alteplase for the Clearance of Occluded Central Venous Access Devices by TIMONEY, J. P, MALKIN, M. G, CONNOR, M, SMALL, T. N, BROWN, A. E, SALTZ, L. B, LEONE, D. M, GROEGER, J. S, HEANEY, M. L, KEEFE, D. L, KLANG, M, LUCARELLI, C. D, MULLER, R. J, ENG, S. L

“…To determine whether cryopreserved solutions of the thrombolytic agent alteplase could be used as a safe, effective, and economically reasonable alternative to…”
Get full text

Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin: A case report by David, Yehuda Ben, Warner, Ellen, Levitan, Maurice, Sutton, David M. S., Malkin, Mark G., Dalmau, Josep O.

“…BACKGROUND Paraneoplastic cerebellar degeneration (PCD) is a remote effect of cancer most frequently associated with carcinoma of the ovary or lung. In many…”
Get full text

Good performance status of long-term disease-free survivors of intracranial gliomas by Kleinberg, L, Wallner, K, Malkin, M G

“…To determine the long-term impact on function of treatment for primary cerebral gliomas, Karnofsky Performance Status, employment history, and memory function…”
Get more information

Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma by Buckner, J C, Malkin, M G, Reed, E, Cascino, T L, Reid, J M, Ames, M M, Tong, W P, Lim, S, Figg, W D

“…To assess the pharmacokinetics, toxicity, and efficacy of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261). We initiated a phase II trial in order to…”
Get more information

Chronic morphine therapy for cancer pain : plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations by PORTENOY, R. K, KHAN, E, LAYMAN, M, LAPIN, J, MALKIN, M. G, FOLEY, K. M, THALER, H. T, CERBONE, D. J, INTURRISI, C. E

“…Morphine-6-glucuronide (M-6-G) is an active metabolite that may contribute to the clinical effects produced by systemic administration of morphine. To help…”
Get full text

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases by ABREY, Lauren E, OLSON, Jon D, RAIZER, Jeffrey J, MACK, Michelle, RODAVITCH, Ann, BOUTROS, Dina Y, MALKIN, Mark G

“…Treatment options for patients with recurrent brain metastases are extremely limited. This study was designed to determine the safety and efficacy of…”
Get full text

Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI by VLASSENKO, A. G, THIESSEN, B, BEATTIE, B. J, MALKIN, M. G, BLASBERG, R. G

“…Changes in [18F]-2-fluoro-2-deoxyglucose (FDG) uptake and gadopentetate dimeglumine (Gd-DTPA) enhancement before and after the first course of treatment with a…”
Get full text

Interstitial irradiation of malignant gliomas by Malkin, M G

“…Beginning in 1986, using software to optimize radiation dosimetry, we have stereotactically placed removable catheters containing high activity I-125 sources…”
Get more information

Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluid by Cibas, E S, Malkin, M G, Posner, J B, Melamed, M R

“…To evaluate the diagnostic utility of flow cytometry (FCM) as compared to cytology, DNA and RNA content of cells were measured in 233 samples of cerebrospinal…”
Get more information

Inability of computed tomography appearance of recurrent malignant astrocytoma to predict survival following reoperation by Wallner, K E, Galicich, J H, Malkin, M G, Arbit, E, Krol, G, Rosenblum, M K

“…Computed tomographic (CT) scans of 39 patients who underwent reoperation for recurrent malignant astrocytoma at Memorial Sloan-Kettering Cancer Center from…”
Get more information

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma by Wallner, K E, Galicich, J H, Krol, G, Arbit, E, Malkin, M G

“…Recurrence patterns of glioblastoma multiforme (25) and anaplastic astrocytoma (9) were studied using CT scans of 34 patients who received all or a portion of…”
Get more information

Turcot's syndrome. Flow cytometric analysis by Newton, H B, Rosenblum, M K, Malkin, M G

“…Turcot's syndrome is a rare, genetically transmittable disease in which patients with colonic polyposis (possibly complicated by the progression to…”
Get more information

Glucosephosphate isomerase as a CSF marker for leptomeningeal metastasis by NEWTON, H. B, FLEISHER, M, SCHWARTZ, M. K, MALKIN, M. G

“…Glucosephosphate isomerase (GPI), also known as phosphohexoisomerase, is a glycolytic enzyme whose activity is elevated in serum and CSF of patients with…”
Get full text

Interstitial brachytherapy of malignant gliomas: the Memorial Sloan-Kettering Cancer Center experience by Malkin, M G

Get more information

Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the brain tumor study group by MALKIN, M. G, GREEN, S. B, MEALEY, J. JR, ROBERTSON, J. T, SELKER, R. G, VAN GILDER, J. C, BYAR, D. P, STRIKE, T. A, BURGER, P. C, VOGEL, F. S, PISTENMAA, D. A, MAHALEY, M. S, RANSOHOFF, J, SHAPIRO, W. R

“…A two-arm randomized clinical trial was performed to determine the efficacy of PCNU and AZQ in the treatment of de novo or recurrent primary brain tumors. An…”
Get full text

Handheld Cellular Telephone Use and Risk of Brain Cancer by Muscat, Joshua E, Malkin, Mark G, Thompson, Seth, Shore, Roy E, Stellman, Steven D, McRee, Don, Neugut, Alfred I, Wynder, Ernst L

“…CONTEXT A relative paucity of data exist on the possible health effects of using cellular telephones. OBJECTIVE To test the hypothesis that using handheld…”
Get full text